FREEMAN NOMINEE LIMITED, MCAF SMART NOMINEES LIMITED, MCIF NO. 6 LIMITED and ... 18 April 2025

Notice of Appointment of Liquidators and Notice to Creditors to Prove Claims Company Nos.: 3683275, 6285527, 2102623 and 3745838 Christopher Carey McCullagh (IP39) and Stephen Mark Lawrence (IP67), Licensed Insolvency Practitioners, were appointed joint and several liquidators of FREEMAN NOMINEE LIMITED, MCAF SMART NOMINEES LIMITED, MCIF NO. 6 LIMITED and MCAF NO. 7 LIMITED (all in liquidation). 18 April 2025 FREEMAN NOMINEE LIMITED at 10.00am, by special resolution of shareholders pursuant to section 241(2)(a) of the Companies Act 1993 (“Act”). MCAF SMART NOMINEES LIMITED at 10.00am, by special resolution of shareholders pursuant to section 241(2)(a) of the Act. MCIF NO. 6 LIMITED at 10.00am, by the board of the company pursuant to section 241(2)(b) of the Act. MCAF NO. 7 LIMITED at 11.00am, by the board of the company pursuant to section 241(2)(b) of the Act. These are solvent liquidations. Prior to liquidation, the companies’ directors signed a declaration for each company that debts will be paid within 12 months, pursuant to section 243A of the Act. Copies of these declarations were delivered to the Registrar. Claims by creditors in the liquidations should be sent to the liquidators by 19 May 2025. Address: PKF Corporate Recovery and Insolvency (Auckland) Limited, PO Box 3678, Auckland 1140. Phone: (09) 302 0521. Email: [email protected]. CHRISTOPHER CAREY McCULLAGH, Joint and Several Liquidator.


Report an error
Category
Appointment/Release of Liquidators
Legislation
Companies Act
Debtor(s)

FREEMAN NOMINEE LIMITED

MCAF SMART NOMINEES LIMITED

MCIF NO. 6 LIMITED

MCAF NO. 7 LIMITED

Region
Auckland
Appointment type
Solvent
Liquidator
Christopher Carey McCullagh
Unknown

Sponsored Content

Please login to view

Login or sign up for a free trial.


Please login to view

Login or sign up for a free trial.


Please login to view

Login or sign up for a free trial.


Please login to view

Login or sign up for a free trial.